Showing results (121-130 of 156) with videos related to
Sort By:
Pageof 16
BMC Cancer|August 29, 2020
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01)Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, et al.Cancers|January 21, 2023
Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, et al.Nature Communications|July 8, 2021
Chaperone-like protein DAY plays critical roles in photomorphogenesisHo-Seok Lee, Ilyeong Choi, Young Jeon, et al.Cancer Research and Treatment|May 4, 2021
Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)Yun-Gyoo Lee, Eun Joo Kang, Bhumsuk Keam, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.Cancers|November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.Oral Oncology|March 8, 2024
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH studyDong Hyun Kim, Seung Taek Lim, Hye Ryun Kim, et al.Translational Lung Cancer Research|August 12, 2022
Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22Hyun Ae Jung, Min Hee Hong, Hyun Woo Lee, et al.Therapeutic Advances in Medical Oncology|September 16, 2024
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignanciesKonstantin Penkov, Igor Bondarenko, Daria Viktorovna Saenko, et al.Cancer Chemotherapy and Pharmacology|February 8, 2012
Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancerDuk Joo Lee, Tae Sung Sohn, Do Hoon Lim, et al.Pageof 16